✦ LIBER ✦

89 Management of stage III non-small-cell lung cancer (NSCLC) in the Greater Manchester and Cheshire Cancer Network (GMCCN): an analysis of current practice

✍ Scribed by Alves, A.; Faivre-Finn, C.; Burt, P.; Chittalia, A.; Coote, J.; Harris, M.; Lander, H.; Lee, L.; Pemberton, L.; Sheikh, H.; Shah, R.; Swindell, R.; Taylor, P.; Blackhall, F.; Bayman, N.

Book ID: 118575030
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 45 KB
Volume: 75
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(12)70090-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

48 Radical management of inoperable stag

48 Radical management of inoperable stage III non-small cell lung cancer (NSCLC) in the Greater Manchester and Cheshire Cancer Network (GMCCN) – an analysis of patient eligibility and justification for treatment

✍ Roberts, H.; Bayman, N.; Swindell, R.; Blackhall, F.; Taylor, P.; Burt, P.; Chit 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

The impact of new agents in the manageme

The impact of new agents in the management of stage III and IV non-small cell lung cancer. An overview

✍ Hansen, Heine H. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 90 KB

The management impact of clinically sign

The management impact of clinically significant incidental lesions detected on staging FDG PET-CT in patients with non-small cell lung cancer (NSCLC): An analysis of 649 cases

✍ Lin, Michael; Ambati, Chaitanya 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 316 KB

P-225 XPD and RRM1 gene polymorphisms pr

P-225 XPD and RRM1 gene polymorphisms predict gemcitabine (gem)/cisplatin (cis)/docetaxel (doc) outcome in stage III non-small-cell lung cancer (NSCLC): a genetic analysis of the Spanish Lung Cancer Group phase II trial 9901

✍ Sarries, Carme; Garrido, Pilar; Nun˜ez, Laura; Roig, Barbara; Ramirez, Jose Luis 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB

PD-068 An exploratory analysis of a phas

PD-068 An exploratory analysis of a phase III study in patients with advanced non-small cell lung cancer (NSCLC): The impact of first-line gemcitabine and platinum therapy on the outcome of second-line therapy with pemetrexed or docetaxel

✍ Bunn, P.; Rosell, R.; Fossella, F.; Perry, M.; Stahel, R.; Barata, F.; Nguyen, B 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB